Vestnik dermatologii i venerologiiVestnik dermatologii i venerologiiВестник дерматологии и венерологии0042-46092313-6294Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov4810.25208/0042-4609-2014-90-4-28-34SHORT COMMUNICATIONКРАТКИЕ СООБЩЕНИЯSeborrheic keratosis: current concepts of pathogenesisСеборейный кератоз: современные представления о патогенезеAleksandrovaA. K.АлександроваА. К.
Russian Federation
veter278@rambler.ruSmolyannikovaV. A.СмольянниковаВ. А.
Russian Federation
veter278@rambler.ruI.M. Sechenov First Moscow State Medical UniversityГБОУ ВПО «Первый Московский государственный медицинский университет им. И. М. Сеченова» Минздрава России24082014904283424082017Copyright ©; 2014, Aleksandrova A.K., Smolyannikova V.A.Copyright ©; 2014, Александрова А.К., Смольянникова В.А.2014Aleksandrova A.K., Smolyannikova V.A.Александрова А.К., Смольянникова В.А.https://creativecommons.org/licenses/by/4.0https://vestnikdv.ru/jour/article/view/48

The article covers problems of seborrheic keratosis. The authors discuss current concepts of the etiology and pathogenesis of the disease paying special attention to the histology and immunohistochemistry of different forms and diverse clinical presentations. They describe Leser - Trelat syndrome as well as potential neoplastic transformation of seborrheic keratomas and their association with malignant skin neoplasms.

Рассматриваются вопросы себорейного кератоза. Обсуждаются современные взгляды на этиологию и патогенез заболевания, особое внимание уделено гистологическим и иммунногистохимическим особенностям разных форм, разнообразию клинических проявлений. Описан синдром Лезера - Трела, показана возможность малигнизации себорейных кератом, их ассоциация со злокачественными новообразованиями кожи.

себорейный кератозиммунногистохимияэндотелин-1онкогены р16р53р63инсулинсиндром Лезера - Трелаseborrheic keratosisimmunohistochemistryendothelin-1р16р53р63 oncogenesinsulinLeser - Trelat syndromeSkripkin U.K., Mordovzeva V.N. Skin and venereal diseases. The management for doctors. M: Medicina; 1999. [Скрипкин Ю.К., Мордовце-ва В.Н. Кожные и венерические болезни. Руководство для врачей. М: Медицина; 1999.]Mordovzeva V.N., Zvetkova G.N., Skin pathology. M: Medicina; 1993. [Мордовцева В.Н., Цветкова Г.М. Патология кожи. М.: Медицина; 1993.]Habif T. P. Skin disease: diagnosis and treatment. Second edition M: MEDpress; 2006 [Хэбиф Т. П. Кожные болезни: Диагностика и лечение; Пер. с англ.; Под общей ред. акад. РАМН, проф. А.А. Кубановой. М.: МЕДпресс-информ; 2006.]Hafner C., Hartmann A., van Oers J.M., Stoehr R., Zwarthoff E.C., Hofstaedter F., Landthaler M. FGFR3 mutations in seborrheic keratoses are already present in flat lesions and associated with age and localization /Mod Pathol. 2007 Aug; 20 (8): 895-903.Gulias-Canizo R., Aranda-Rabago J., Rodriguez-Reyes A.A. Seborrheic keratosis of conjunctiva: a case report.Arch Soc Esp Oftalmol. 2006 Apr; 81 (4): 217-9.Kim J.H., Bae H.W., Lee K.K., Kim T.I., Kim E.K. Seborrheic keratosis of the conjunctiva: a case report. Korean J Ophthalmol. 2009 Dec; 23 (4): 306-8.Kwon O.S., Hwang E.J., Bae J.H., Park H.E., Lee J.C., Youn J.I., et al. Seborrheic keratosis in the Korean males: Causative role of sunlight. Photodermatol Photoimmunol Photomed. 2003; 19 (2): 73-80.Noiles K., Vender R. Are all seborrheic keratoses benign? Review of the typical lesion and its variants. J Cutan Med Surg. 2008 Sep-Oct; 12 (5): 203-10.Zvetkova G.M., Mordovzeva V.V., Vavilov A.M., Mordovzev V. V. Pathomorfology of skin diseases. M: Medicina; 2003. [Цветкова Г.М., Мордовцева В.В., Вавилов А.М., Мордовцев В.Н. Патоморфология болезней кожи. М.: Медицина; 2003.]Yoshimi N., Imai Y., Kakuno A., Tsubura A., Yamanishi K., Kurokawa I. Epithelial keratin and filaggrin expression in seborrheic keratosis: evaluation based on histopathological classification. International J Dermatol. 2013 Jun 20: 34-36.Requena L., Kutzner H. Seborrheic keratosis with pseudorosettes and adamantinoid seborrheic keratosis: two new histopathologic variants. J Cutan Pathol. 2006 Sep; 33 Suppl 2: 42-5.Christian Hafner, Johanna M.M. van Oers, Arndt Hartmann, Michael Landthaler, High Frequency of FGFR3 Mutations in Adenoid Seborrheic Keratoses/ Journal of Investigative Dermatology (2006) 126, 2404-2407.Mekni A., Bouraoui S., Kchir N., Kort R., Bellil K.E. May A. Malignancy arising in seborrheic keratosis: two cases report. Tunis Med. 2003 Oct; 81 (10): 835-8.Bruecks A.K., Kalia S., Trotter M.J. Overexpression of p27KIP1 in seborrheic keratosis. J Cutaneous Medicine and Surgery. 2007 Sep-Oct; 11 (5): 174-8.Meibodi N.T., Nahidi Y., Meshkat Z., Esmaili H., Gharib M., Gholoobi A. N. Evidence of Human Papillomaviruses in Non-genital Seborrheic Keratosis. Indian J Dermatol. 2013 Jul; 58 (4): 326.Lebedeva U.V., Davidov A.B. dinical assessment of prevalence of seborrheic keratosis face skin and a neck among oncological patients. Stomatologia 2009; (5): 45-48. [Лебедева Ю.В., Давыдов А.Б. Клиническая оценка распространенности себорейного кератоза кожи лица и шеи среди онкологических больных. Стоматология 2009; (5): 45-48.]Groesser L., Herschberger E., Landthaler M., Hafner C. FGFR3, PIK3CA and RAS mutations in benign lichenoid keratosis. Br J Dermatol. 2012 Apr; 166 (4): 784-8.Jee H., Lee N.R., Ahn S.K. Case of seborrheic keratosis with underlying basal cell carcinoma suggesting a collision tumor. J Dermatol. 2013 Oct; 40 (10): 837-9.Laing M.E., O’Keane C., Murphy G.M. Basal cell carcinoma arising in a seborrhoeic keratosis. Clin Exp Dermatol. 2009 Oct; 34 (7): e371-2.Lee J.Y., Lin M.H. Pigmented malignant hidroacanthoma simplex mimicking irritated seborrheic keratosis. J Cutan Pathol. 2006 Oct; 33 (10): 705-8.Akasaka T., Kon S. Two cases of basal cell carcinoma arising in seborrheic keratosis. J Dermatol. 1997 May; 24 (5): 322-7.Izikson L., Sober A.J., Mihm M.C. Jr., Zembowicz A. Prevalence of melanoma clinically resembling seborrheic keratosis: analysis of 9204 cases. Arch Dermatol. 2002 Dec; 138 (12): 1562-6.Vun Y., De’Ambrosis B., Spelman L., Muir J.B., Yong-Gee S., Wagner G., Lun K. Seborrhoeic keratosis and malignancy: collision tumour or malignant transformation? Australas J Dermatol. 2006 May; 47 (2): 106-8.Rajabi P., Adibi N., Nematollahi P., Heidarpour M., Eftekhari M., Siadat A.H. Bowenoid transformation in seborrheic keratosis: A retrospective analysis of 429 patients. J Res Med Sci. 2012 Mar; 17 (3): 217-21.Thomas I., Kihiczak N.I., Rothenberg J., Ahmed S., Schwartz R.A. Melanoma within the seborrheic keratosis. Dermatol Surg. 2004 Apr; 30 (4 Pt 1): 559-61.Terada T., Kamo M, Baba Y., Sugiura M. Microinvasive squamous cell carcinoma arising within seborrheic keratosis. Cutis. 2012 Oct; 90 (4): 176-8.Ishida M., Ohsato N., Okabe H. Basal cell carcinoma arising within a seborrheic keratosis with respect to immunohistochemical characteristics. Oncol Lett. 2011 Jul; 2 (4): 625-627.Lim C. Seborrhoeic keratoses with associated lesions: a retrospective analysis of 85 lesions. Australas J Dermatol. 2006 May; 47 (2): 109-13.Hafner C., Vogt T., Landthaler M., Müsebeck J. Somatic FGFR3 and PIK3CA mutations are present in familial seborrhoeic keratoses. Br J Dermatol. 2008 Jul; 159 (1): 214-7.Ko C.J., Shintaku P., Binder S.W. Comparison of benign keratoses using p53, bcl-1, and bcl 2. J Cutan Pathol. 2005 May; 32 (5): 356-9Wrone D.A., Yoo S., Chipps L.K., Moy R.L. The expression of p63 in actinic keratoses, seborrheic keratosis, and cutaneous squamous cell carcinomas. Dermatol Surg. 2004 Oct; 30 (10): 1299-302.Heaphy M.R. Jr., Millns J.L., Schroeter A.L. The sign of Leser-Trelat in a case of adenocarcinoma of the lung. J Am Acad Dermatol. 2000; 43: 386-390. doi: 10.1016/S0190-9622 (00)70301-X.Ellis D.L., Kafka S.P., Chow J.C. Melanoma, growth factors, acanthosis nigricans, the sign of Leser-Trelat, and multiple acrochordons. A possible role for alpha-transforming growth factor in cutaneous paraneoplastic syndromes. N Engl J Med. 1987; 317 (25): 1582-1587.Ponti G., Luppi G., Losi L., Giannetti A., Seidenari S. Leser-Tre'lat syndrome in patients affected by six multiple metachronous primitive cancers. J Hematology Oncol. 2010 Jan 11; 3: 2.Saraiya A., Al-Shoha A., Brodell R.T. Hyper-insulinemia associated with acanthosis nigricans, finger pebbles, acrochordons, and the sign of Leser-Trelat. Endocr Pract. 2013 MayJun; 19 (3): 522-5.Blomberg M., Jeppesen E.M., Skovby F., Benfeldt E. FGFR3 mutations and the skin: report of a patient with a FGFR3 gene mutation, acanthosis nigricans, hypochondroplasia and hyperinsulinemia and review of the literature. Dermatology. 2010; 220 (4): 297-30.Wolff K.L., Goldsmith A.L. et al. Fitzpatrick s Dermatology in General Medicine, seventh edition, McGraw-Hill Medical., 2013: 1635-36.Wieland C.N., Kumar N. Sign of Leser-Trelat. Int J Dermatol. 2008 Jun; 47 (6): 643-4.Smetnik V. I., Kulakov V. I. The management on a klimakteriya. M: Medical information agency; 2001. [Сметник В.П., Кулакова В.И. Руководство по климактерию. М: Медицинское информационное агентство. 2001.]Broekaert D., Leigh I.M., Lane E.B., Van Muijen G.N., Ramaekers F.C., De Bersaques J. An immunohistochemical and histochemical study of cytokeratin, involucrin and transglutaminase in seborrhoeic keratosis. Arch Dermatol Res. 1993; 285 (8): 482-90.Nindl M., Nakagawa H., Furue M., Ishibashi Y. Simple epithelial cytokeratin-expression in seborrheic keratosis J Cutan Pathol. 1992 Oct; 19 (5): 415-22.Vestergaard M.E., Kossard S., Murrell D.F. Seborrhoeic keratoses appearing in sites of previous psoriasis plaques during treatment with efalizumab. Clin Experiment. Dermatol. 2009 Dec; 34 (8): e564-6.Hida Y., Kubo Y., Arase S. Activation of fibroblast growth factor receptor 3 and oncogene-induced senescence in skin tumours. Br J Dermatol. 2009 Jun; 160 (6): 1258-63.Nakamura S., Nishioka K. Enhanced expression of p16 in seborrhoeic keratosis; a lesion of accumulated senescent epidermal cells in G1 arrest. Br J Dermatol. 2003 Sep; 149 (3): 560-5.Hafner C., Toll A., Fernandez-Casado A., Earl J., et al. Multiple oncogenic mutations and clonal relationship in spatially distinct benign human epidermal tumors. Proceedings Natl Acad Sci U. S. A. 2010 Nov 30; 107 (48): 20780-5.Hafner C., Kamenisch Y., Landthaler M., Berneburg M. Distinct profile of the mitochondrial DNA common deletion in benign skin lesions. Experimental Dermatol. 2011 Feb; 20 (2): 151-3.Logie A., Dunois-Larde C., Rosty C. et al. Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans. Hum Mol. Genet 14: 1153-1160.Karoui M., Zimmermann U., Degott C. et al. No evidence of somatic FGFR3 mutation in various types of carcinoma. Onkogene 2001 № 20: 5059-61.Mabuchi T., Akasaka E., Kondoh A., Umezawa Y., Matsuyama T., Ozawa A. Seborrheic keratosis that follows Blaschko’s lines. Dermatol. 2008 May; 35 (5): 301-3.Ceylan C., Alper S, Kilinç I. Leser-Trelat sign. Int J Dermatol. 2002 Oct; 41 (10): 687-8.Kamiya M., Takeuchi Y., Katho M., Yokoo H., Sasaki A., Nakazato Y. Expression of p73 in normal skin and proliferative skin lesions. Pathol Int. 2004 Dec; 54 (12): 890-5.Shamsadini S., Wadji M.B., Shamsadini A. Surrounding ipsilateral eruptive seborrheic keratosis as a warning sign ofintraductal breast carcinoma and Paget’s disease (Leser Trelat sign). Dermatol Online J. 2006 Oct 31; 12 (6): 27.Nanney L.B., Ellis D.L., Levine J., King L.E. Epidermal growth factor receptors in idiopathic and virally induced skin diseases. Am J Pathol. 1992 Apr; 140 (4): 915-25.Puizina-Ivic N., Sapunar D., Marasovic D., Miric L. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis. Collegium Antropol. 2008 Oct; 32.Akgül B., Cooke J.C., Storey A. HPV-associated skin disease. J Pathol. 2006 Jan; 208 (2): 165-75.Forslund O., Ly H., Reid C., Higgins G. A broad spectrum of human papillomavirus types is present in the skin of Australian patients with non-melanoma skin cancers and solar keratosis Br J Dermatol. 2003 Jul; 149 (1): 64-73.Tardio J.C., Bancalari E., Moreno A., Martin-Fragueiro L.M. Genital seborrheic keratoses are human papillomavirus-related lesions. A linear array genotyping test study. 2012 Jun; 120 (6): 477-83.Lee E.S., Whang M.R., Kang W.H. Absence of human papillomavirus DNA in nongenital seborrheic keratosis. J Korean Med Sci. 2001 Oct; 16 (5): 619-22.Kladova A.U. Association of the epitelian tumors of skin with Human papilloma viruses. Doctor 2011; (13): 5-7. [Кладова А.Ю. Ассоциация эпителиальных опухолей кожи с вирусами папилломы человека. Доктор 2011; (13): 5-7.]Gushi A., Kanekura T., Kanzaki T., Eizuru Y. Detection and sequences of human papillomavirus DNA in nongenital seborrhoeic keratosis of immunopotent individuals. J Dermatol Sci. 2003 Apr; 31 (2): 143-9.Meyer T., Arndt R., Christophers E., Nindl I. & Stockfleth E. (2001). Importance of human papillomaviruses for the development of skin cancer. Cancer Detect Prev 25, 533-547.Pfister H. & Ter Schegget J. Role of HPV in cutaneous premalignant and malignant tumors. Clin Dermatol 1997; 15: 335-347.Zhu W.Y., Leonardi C., Penneys N.S. Detection of human papillomavirus DNA in seborrheic keratosis by polymerase chain reaction J Dermatol Sci. 1992 Nov; 4 (3): 166-71.Zhang Y., Tang L., Su M., Eisen D., Zloty D., Warshawski L., Zhou Y. Expression of endothelins and their receptors in nonmelanoma skin cancers. J Cutan Med Surg. 2006 Nov-Dec; 10 (6): 269-76.Manaka L., Kadono S., Kawashima M., Kobayashi T., Imokawa G.The mechanism of hyperpigmentation in seborrhoeic keratosis involves the high expression of endothelin-converting enzyme-1alpha and TNF-alpha, which stimulate secretion of endothelin 1. Br J Dermatol. 2001 Dec; 145 (6): 895-903.Takenaka Y., Hoshino Y., Nakajima H., Hayashi N., Kawashima M., Imokawa G. Paracrine cytokine mechanisms underlying the hyperpigmentation of seborrheic keratosis in covered skin areas. J Dermatol. 2013 Jul; 40 (7): 533-42.